Clinical studies have observed elevated levels of CD4<sup>+</sup>CD28<sup>null</sup> T cells, Th17/Treg cells, CD8<sup>+</sup> cells, and related markers in the peripheral blood or atrial tissue of AF patients, correlating with disease severity and cardiovascular events. The gene discussed is CD8A; the disease is atrial fibrillation.